Decoy Therapeutics (DCOY) Common Equity (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Common Equity of $3.9 million for Q1 2026, up 6167.39% year-over-year from $61866.0 in Q1 2025, and down 34.16% quarter-over-quarter from $5.9 million in Q4 2025.
Decoy Therapeutics (DCOY) Common Equity (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Common Equity for 13 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 6167.39% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 6167.39% YoY), while the FY2025 annual figure was $5.9 million, up 289.56% from the prior year.
- Common Equity fell to $3.9 million in Q1 2026 per DCOY's latest filing, from $5.9 million in the prior quarter.
- Across five years, Common Equity topped out at $33.4 million in Q1 2022 and bottomed at -$829724.0 in Q2 2025.
- Historically, Common Equity has averaged $8.3 million across 5 years, with a median of $5.3 million in 2023.
- Annual changes were most pronounced in 2025 — Common Equity plunged 134.93% — and 2026, when it soared 6167.39%.
- Decoy Therapeutics' Common Equity stood at $10.4 million in 2022, then sank by 49.09% to $5.3 million in 2023, then sank by 71.41% to $1.5 million in 2024, then soared by 289.56% to $5.9 million in 2025, then tumbled by 34.16% to $3.9 million in 2026.
- Business Quant data shows DCOY's Common Equity at $3.9 million in Q1 2026, $5.9 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 9.79 Bn |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | 4.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | -829,724.00 |
| Mar 31, 2025 | 61,866.00 |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 3.65 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 6.08 Mn |
| Jun 30, 2023 | 8.41 Mn |
| Mar 31, 2023 | 5.56 Mn |
| Dec 31, 2022 | 10.38 Mn |
| Sep 30, 2022 | 16.61 Mn |
| Jun 30, 2022 | 30.88 Mn |
| Mar 31, 2022 | 33.42 Mn |
| Dec 31, 2021 | 38.72 Mn |
| Sep 30, 2021 | 42.65 Mn |